NASDAQ:PMVP

Pmv Pharmaceuticals Stock Insider Trading

Healthcare > Biotechnology

Buy PMVP

*Your capital is at risk

$1.16

-0.0200 (-1.69%)

At Close: Jun 03, 2026

PMV Pharmaceuticals Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -34.59. In total, the insiders bought 9.65M and sold 4.53M PMVP shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	-34.59
● Buy	9.65M shares
● Sell	4.53M shares
64% Buy Activity Negligible or No Correlation
Buy Signal Low Confidence Mar 05, 2026 Analysis Breakdown: Signal is highly questionable due to a strongly contradictory negative Insider Power Score of -34.59. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Mar 05, 2026 Buy	Employee Stock Option (right to buy) A-Award	Carulli Michael Chief Financial Officer	C-Suite Officer	240 000 Value: $367.2K
Mar 05, 2026 Buy	Employee Stock Option (right to buy) A-Award	Ticktin Robert General Counsel & COO	C-Suite Officer	319 270 Value: $488.5K
Mar 05, 2026 Buy	Employee Stock Option (right to buy) A-Award	Jalota Deepika Chief Development Officer	Officer	303 310 Value: $464.1K
Mar 05, 2026 Buy	Employee Stock Option (right to buy) A-Award	Mack David Henry President And CEO	CEO / President	744 960 Value: $1.14M
Oct 27, 2025 Buy	Common Stock M-Exempt	Mack David Henry President And CEO	CEO / President	220 643 Value: $302.3K
Oct 27, 2025 Buy	Employee Stock Option (right to buy) M-Exempt	Mack David Henry President And CEO	CEO / President	220 643 Value: $302.3K
Oct 23, 2025 Sell	Common Stock S-Sale	Orbimed Advisors Llc 10 Percent Owner	10% Owner	1 000 000 Value: $1.52M
Sep 10, 2025 Sell	Common Stock S-Sale	Orbimed Advisors Llc 10 Percent Owner	10% Owner	500 000 Value: $900.0K
Sep 10, 2025 Sell	Common Stock S-Sale	Orbimed Advisors Llc 10 Percent Owner	10% Owner	500 000 Value: $900.0K
Jul 01, 2025 Sell	Common Stock S-Sale	Ticktin Robert General Counsel & COO	C-Suite Officer	23 151 Value: $24.7K
Jul 01, 2025 Sell	Common Stock S-Sale	Jalota Deepika Chief Development Officer	Officer	33 065 Value: $35.2K
Jul 01, 2025 Sell	Common Stock S-Sale	Carulli Michael Chief Financial Officer	C-Suite Officer	28 249 Value: $30.1K
Jul 01, 2025 Sell	Common Stock S-Sale	Mack David Henry President And CEO	CEO / President	58 411 Value: $62.2K
Jul 01, 2025 Sell	Common Stock S-Sale	Mack David Henry President And CEO	CEO / President	58 411 Value: $62.2K
Jul 01, 2025 Sell	Common Stock S-Sale	Carulli Michael Chief Financial Officer	C-Suite Officer	28 249 Value: $30.1K
Jul 01, 2025 Sell	Common Stock S-Sale	Jalota Deepika Chief Development Officer	Officer	33 065 Value: $35.2K
Jul 01, 2025 Sell	Common Stock S-Sale	Ticktin Robert General Counsel & COO	C-Suite Officer	23 151 Value: $24.7K
Jun 05, 2025 Buy	Stock Option (right to buy) A-Award	Stelzer Laurie Director	Director	33 500 Value: $31.8K
Jun 05, 2025 Buy	Stock Option (right to buy) A-Award	Levine Arnold J Director	Director	33 500 Value: $31.8K
Jun 05, 2025 Buy	Stock Option (right to buy) A-Award	Heyman Richard A. Director	Director	33 500 Value: $31.8K
Jun 05, 2025 Buy	Stock Option (right to buy) A-Award	Gallagher Carol Giltner Director	Director	33 500 Value: $31.8K
Jun 05, 2025 Buy	Stock Option (right to buy) G-Gift	Gallagher Carol Giltner Director	Director	33 500 Value: $31.8K
Jun 05, 2025 Sell	Stock Option (right to buy) G-Gift	Gallagher Carol Giltner Director	Director	33 500 Value: $31.8K
Jun 05, 2025 Buy	Stock Option (right to buy) A-Award	Flowers Kirsten Director	Director	33 500 Value: $31.8K
Jun 05, 2025 Buy	Stock Option (right to buy) A-Award	Baum Charles M Director	Director	33 500 Value: $31.8K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT PMV PHARMACEUTICALS INC.

PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also developing mutant p53 programs, including Wild-type p53 Induced-Phosphatase, R282W, and R273H, as well a...

Read Full Profile Here